<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>128(8)</volume><submitter>Cuoco S</submitter><funding>Università degli Studi di Salerno</funding><pubmed_abstract>&lt;h4>Background&lt;/h4>The evidence about the language performance profile of multiple system atrophy (MSA) is limited, but its definition may lead to a more comprehensive characterization of the disorder and contribute to clarify the involvement of the basal ganglia in language abilities.&lt;h4>Objective&lt;/h4>The objectives of the study were: (1) to evaluate the reliability of the Screening for Aphasia in NeuroDegeneration (SAND) in MSA patients; (2) compare the linguistic profiles among MSA and Parkinson's disease (PD) patients and healthy controls (HC), and (3) assess relationships between language impairment and cognitive status and MSA motor subtypes.&lt;h4>Methods and results&lt;/h4>Forty patients with a diagnosis of MSA, 22 HC and 17 patients with PD were enrolled in the present study. By excluding the writing task that showed a poor acceptability, we showed that the MSA-tailored SAND Global Score is an acceptable, consistent and reliable tool to screen language disturbances in MSA. MSA patients performed worse than HC, but not than PD, in MSA-tailored SAND Global Score, repetition, reading and semantic association tasks. We did not find significant differences between MSA phenotypes. MSA patients with mild cognitive impairment-multiple domain presented worse language performances as compared to MSA patients with normal cognition and mild cognitive impairment-single domain.&lt;h4>Conclusion&lt;/h4>The MSA-tailored SAND Global Score is a consistent and reliable tool to screen language disturbances in MSA. Language disturbances characterize MSA patients irrespective of disease phenotype, and parallel the decline of global cognitive functions.</pubmed_abstract><journal>Journal of neural transmission (Vienna, Austria : 1996)</journal><pagination>1195-1203</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8322009</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>The language profile in multiple system atrophy: an exploratory study.</pubmed_title><pmcid>PMC8322009</pmcid><pubmed_authors>Cappa S</pubmed_authors><pubmed_authors>Barone P</pubmed_authors><pubmed_authors>Picillo M</pubmed_authors><pubmed_authors>Erro R</pubmed_authors><pubmed_authors>Carotenuto I</pubmed_authors><pubmed_authors>Catricala E</pubmed_authors><pubmed_authors>Cuoco S</pubmed_authors><pubmed_authors>Pellecchia MT</pubmed_authors></additional><is_claimable>false</is_claimable><name>The language profile in multiple system atrophy: an exploratory study.</name><description>&lt;h4>Background&lt;/h4>The evidence about the language performance profile of multiple system atrophy (MSA) is limited, but its definition may lead to a more comprehensive characterization of the disorder and contribute to clarify the involvement of the basal ganglia in language abilities.&lt;h4>Objective&lt;/h4>The objectives of the study were: (1) to evaluate the reliability of the Screening for Aphasia in NeuroDegeneration (SAND) in MSA patients; (2) compare the linguistic profiles among MSA and Parkinson's disease (PD) patients and healthy controls (HC), and (3) assess relationships between language impairment and cognitive status and MSA motor subtypes.&lt;h4>Methods and results&lt;/h4>Forty patients with a diagnosis of MSA, 22 HC and 17 patients with PD were enrolled in the present study. By excluding the writing task that showed a poor acceptability, we showed that the MSA-tailored SAND Global Score is an acceptable, consistent and reliable tool to screen language disturbances in MSA. MSA patients performed worse than HC, but not than PD, in MSA-tailored SAND Global Score, repetition, reading and semantic association tasks. We did not find significant differences between MSA phenotypes. MSA patients with mild cognitive impairment-multiple domain presented worse language performances as compared to MSA patients with normal cognition and mild cognitive impairment-single domain.&lt;h4>Conclusion&lt;/h4>The MSA-tailored SAND Global Score is a consistent and reliable tool to screen language disturbances in MSA. Language disturbances characterize MSA patients irrespective of disease phenotype, and parallel the decline of global cognitive functions.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-19T20:40:31.266Z</modification><creation>2022-02-11T08:38:46.709Z</creation></dates><accession>S-EPMC8322009</accession><cross_references><pubmed>34216238</pubmed><doi>10.1007/s00702-021-02372-6</doi></cross_references></HashMap>